The Effect of Moringa Leaf Extract (Moringa Oliefera) On Triglyceride Levels in Streptozotocin Induced Type 2 Diabetes White Wistar Rats
https://doi.org/10.33860/jik.v17i3.3409
Keywords:
Rat triglycerides, Moringa leaf extract, Blood Glucose, StreptozotocinAbstract
High blood sugar levels can hasten the liver's production of triglycerides. Normally, the body uses glucose as one of its energy sources. This study aimed to determine changes in the weight of mice and decrease triglyceride levels in mice by administering Moringa leaf extract. This type of research is a pure experiment with a "pre and post-randomized controlled group" design. This was carried out using a repeated ANOVA test, a sample of 25 mice. The research used male white rats of the Wistar strain, which were induced with STZ (Streptozotocin) at a dose of 65 mg/kg BW and NA 230 mg/kg BW, where the experimental animals were divided into 5 groups, namely negative control group, positive control and 3 treatment groups given the extract. from Moringa leaves at a dose of 200, 300, 400 mg/kg BW of rats. The optimal dose of Moringa leaves for losing weight and reducing triglyceride levels in mice is a dose of 400 mg/kg of mouse body weight. Glibenclamide (0.09 mg/kg rat body weight) and Moringa leaf extract (300 mg/kg rat body weight) are each the optimal dose to reduce glucose levels in rats. With a p value for each variable of 0.001, administration of Moringa leaf extract affected body weight, glucose and triglyceride levels in white Wistar rats with type 2 diabetes induced by streptozotocin. These findings suggest that Moringa leaf extract may have potential therapeutic effects in treating diabetes-related complications.
References
Maresova P, Javanmardi E, Barakovic S, Barakovic Husic J, Tomsone S, Krejcar O, Kuca K. Consequences of chronic diseases and other limitations associated with old age–a scoping review. BMC public health. 2019 Dec;19:1-7.
Giani E, Scaramuzza AE, Zuccotti GV. Impact of new technologies on diabetes care. World journal of diabetes. 2015 Jul 7;6(8):999.
Hirose M, Beverly EA, Weinger K. Quality of life and technology: impact on children and families with diabetes. Current diabetes reports. 2012 Dec;12:711-20.
Woessner MN, Tacey A, Levinger-Limor A, Parker AG, Levinger P, Levinger I. The evolution of technology and physical inactivity: the good, the bad, and the way forward. Frontiers in public health. 2021 May 28;9:655491.
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Comprehensive physiology. 2012 Apr;2(2):1143.
Dhuli K, Naureen Z, Medori MC, Fioretti F, Caruso P, Perrone MA, Nodari S, Manganotti P, Xhufi S, Bushati M, Bozo D. Physical activity for health. Journal of Preventive Medicine and Hygiene. 2022 Jun;63(2 Suppl 3):E150.
Briguglio M, Vitale JA, Galentino R, Banfi G, Zanaboni Dina C, Bona A, Panzica G, Porta M, Dell’Osso B, Glick ID. Healthy eating, physical activity, and sleep hygiene (HEPAS) as the winning triad for sustaining physical and mental health in patients at risk for or with neuropsychiatric disorders: considerations for clinical practice. Neuropsychiatric disease and treatment. 2020 Jan 8:55-70.
Alotaibi T, Almuhanna R, Alhassan J, Alqadhib E, Mortada E, Alwhaibi R. The relationship between technology use and physical activity among typically-developing children. InHealthcare 2020 Nov 17 (Vol. 8, No. 4, p. 488). MDPI.
L. J. M. Wachira, S. K. Muthuri, S. A. Ochola, V. O. Onywera, and M. S. Tremblay, “Screen-based sedentary behaviour and adiposity among school children: Results from international study of childhood obesity, lifestyle and the environment (iscole) - Kenya,” PLoS One, vol. 13, no. 6, pp. 1–15, 2018, doi: 10.1371/journal.pone.0199790.
Glimcher LH, Lee AH. From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. Annals of the New York Academy of Sciences. 2009 Sep;1173:E2-9.
Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Current cardiology reports. 2011 Dec;13:544-52.
Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World journal of diabetes. 2015 Oct 10;6(13):1246.
Gugliucci A. Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux. Journal of Clinical Medicine. 2023 Jun 29;12(13):4399.
Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids in health and disease. 2017 Dec;16:1-2.
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine. 2014 Aug;5(8):927.
Tian D, Meng J. Exercise for prevention and relief of cardiovascular disease: prognoses, mechanisms, and approaches. Oxidative Medicine and Cellular Longevity. 2019 Apr 9;2019.
Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. Cmaj. 2007 Apr 10;176(8):1113-20.
Diwan AD, Ninawe AS, Harke SN. Gene editing (CRISPR-Cas) technology and fisheries sector. Canadian Journal of Biotechnology. 2017;1(2):65-72.
Górska-Warsewicz H, Rejman K, Laskowski W, Czeczotko M. Milk and dairy products and their nutritional contribution to the average polish diet. Nutrients. 2019 Aug 1;11(8):1771.
Setyawati T, Adawiyah R, Walanda RM, Chandra R. Effectiveness of moringa oleifera on triglyceride levels in diabetic wistar rats (Rattus norvegicus) induced with streptozotocin (STZ). InIOP Conference Series: Earth and Environmental Science 2022 Nov 1; 1075, (1). IOP Publishing.
Nakai K, Umehara M, Minamida A, Yamauchi-Sawada H, Sunahara Y, Matoba Y, Okuno-Ozeki N, Nakamura I, Nakata T, Yagi-Tomita A, Uehara-Watanabe N. Streptozotocin induces renal proximal tubular injury through p53 signaling activation. Scientific Reports. 2023 May 29;13(1):8705.
Cheng D, Liang B, Li Y. Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. BioMed research international. 2013 Jan 1;2013.
Martín-Carro B, Donate-Correa J, Fernández-Villabrille S, Martín-Vírgala J, Panizo S, Carrillo-López N, Martínez-Arias L, Navarro-González JF, Naves-Díaz M, Fernández-Martín JL, Alonso-Montes C. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities. International Journal of Molecular Sciences. 2023 Jun 18;24(12):10309.
Wang-Fischer Y, Garyantes T. Improving the reliability and utility of streptozotocin-induced rat diabetic model. Journal of diabetes research. 2018 Sep 23;2018.
Damasceno DC, Netto AO, Iessi IL, Gallego FQ, Corvino SB, Dallaqua B, Sinzato YK, Bueno A, Calderon ID, Rudge MV. Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes. BioMed research international. 2014 Oct;2014.
Patil JS, Naikawadi AA, Moharir G, Bharatha A. Effect of Glucose Tolerance Factor (GTF) on Lipid Profile, Blood Glucose Levels, and Food Intake in Streptozotocin-Induced Diabetes in Rats. Maedica. 2020 Jun;15(2):238.
Kifle ZD, Belayneh YM. Antidiabetic and anti-hyperlipidemic effects of the crude hydromethanol extract of Hagenia abyssinica (Rosaceae) leaves in streptozotocin-induced diabetic mice. Diabetes, Metabolic Syndrome and Obesity. 2020 Oct 29:4085-94.
Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. International journal of molecular sciences. 2021 Jul 16;22(14):7644.
Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO, Rahman MA, Hannan MA, Uddin MJ, Pang MG. Role of insulin in health and disease: an update. International journal of molecular sciences. 2021 Jun 15;22(12):6403.
Karakas SE. PCOS and Insulin Resistance. A Case-Based Guide to Clinical Endocrinology. 2022:487-9.
Zhu BT. Pathogenic mechanism of autoimmune diabetes mellitus in humans: potential role of streptozotocin-induced selective autoimmunity against human islet β-cells. Cells. 2022 Jan 31;11(3):492.
Pang G, Xie J, Chen Q, Hu Z. Energy intake, metabolic homeostasis, and human health. Food Science and Human Wellness. 2014 Sep 1;3(3-4):89-103.
Souto G, Donapetry C, Calviño J, Adeva MM. Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metabolic Syndrome and Related Disorders. 2011 Aug 1;9(4):247-53.
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. International journal of molecular sciences. 2018 Oct 26;19(11):3342.
Althaher AR. An Overview of Hormone-Sensitive Lipase (HSL). The Scientific World Journal. 2022 Dec 8;2022.
Kojta I, Chacińska M, Błachnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 2020 May 3;12(5):1305.
Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?. World journal of diabetes. 2014 Aug 8;5(4):444.
Madhu SV. World diabetes day 2015: healthy living & diabetes. The Indian Journal of Medical Research. 2015 Nov;142(5):503.
Vergara-Jimenez M, Almatrafi MM, Fernandez ML. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants. 2017 Nov 16;6(4):91.
Kashyap P, Kumar S, Riar CS, Jindal N, Baniwal P, Guiné RP, Correia PM, Mehra R, Kumar H. Recent advances in Drumstick (Moringa oleifera) leaves bioactive compounds: Composition, health benefits, bioaccessibility, and dietary applications. Antioxidants. 2022 Feb 16;11(2):402.
Gopalakrishnan L, Doriya K, Kumar DS. Moringa oleifera: A review on nutritive importance and its medicinal application. Food science and human wellness. 2016 Jun 1;5(2):49-56.
Wu YY, Xu YM, Lau AT. Anti-cancer and medicinal potentials of Moringa isothiocyanate. Molecules. 2021 Dec 11;26(24):7512.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.